日本脑膜瘤风险的全基因组关联研究:一项多中心前瞻性研究
该研究为日本首个脑膜瘤全基因组关联研究(GWAS),纳入401例日本脑膜瘤患者和50,876名日本 ancestry 对照,未发现达到全基因组显著性的遗传变异,先前报道的风险变异 rs11012732 和 rs2686876 在日本人群中因低次要等位基因频率未显示显著关联。
要点
- 日本脑膜瘤患者401例与Biobank Japan对照50,876名进行GWAS,未发现全基因组显著变异(P<5×10⁻⁸)。
- 先前报道的风险变异 rs11012732 和 rs2686876 在日本人群中因低次要等位基因频率未显示显著关联。
- 这是东亚人群首个脑膜瘤GWAS,预期有助于推动脑膜瘤GWAS研究发展。
核心结论
- 这是东亚人群首个脑膜瘤GWAS,未发现全基因组显著性的遗传变异,先前报道的风险变异 rs11012732 和 rs2686876 在日本人群中因低次要等位基因频率未显示显著关联。
研究设计与样本
- 多中心前瞻性病例对照研究,纳入日本5家机构的401例日本脑膜瘤患者和50,876名日本 ancestry 的Biobank Japan对照参与者。
主要发现
- 质量控制后得到536,319个变异,填充后常染色体得到8,224,735个变异、X染色体得到224,820个变异。
- GWAS未发现达到全基因组显著性(P<5×10⁻⁸)的遗传变异。
- 先前报道的风险变异 rs11012732 和 rs2686876 因日本人群低次要等位基因频率未显示显著关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although meningiomas are the most common primary intracranial tumors, their genetic etiologies have not been fully elucidated. To date, only two genome-wide association studies (GWASs) have focused on European ancestries, despite ethnic differences in the incidence of meningiomas. The aim of this study was to conduct the first GWAS of Japanese patients with meningiomas to identify the SNPs associated with meningioma susceptibility. METHODS: In this multicenter prospective case-control study, we studied 401 Japanese patients with meningioma admitted in five institutions in Japan, and 50,876 control participants of Japanese ancestry enrolled in Biobank Japan. RESULTS: The quality control process yielded 536,319 variants and imputation resulted in 8,224,735 variants on the autosomes and 224,820 variants on the X chromosomes. This GWAS eventually revealed no genetic variants with genome-wide significance (P < 5 × 10 - 8) and observed no significant association in the previously reported risk variants rs11012732 and rs2686876 due to low minor allele frequency in the Japanese population. CONCLUSION: This is the first GWAS of meningiomas in East Asian populations and is expected to contribute to the development of GWAS research for meningiomas.
引用
- Yamada S, Umehara T, Sonehara K, et al. Genome-wide association study on meningioma risk in Japan: a multicenter prospective study. J Neurooncol. 2024. PMID: 39002029. doi:10.1007/s11060-024-04727-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。